Patient dies during Zafgen's obesity drug trial
(Reuters) - Zafgen Inc said a patient died during a late-stage trial testing the company's drug to treat Prader-Willi syndrome, a rare genetic disorder that leads to obesity.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Eating Disorders & Weight Management | Genetics | Health | Obesity | Prader-Willi Syndrome